March 17th 2023
Yesterday, the FDA took a major step toward officially approving Paxlovid. Catch up on this story and the other top COVID-19 news updates from the past week.
If The PREP Act Sunsets, it Will Affect Pharmacists' Role With Vaccines, Access to Care
February 24th 2023A new report shows these providers are playing a larger role in vaccine administration, but without federal legislation codifying PREP, half the US states could determine not to continue this path for pharmacists and take away this now vital responsibility.
Read More
As US COVID-19 Vaccine Policy Pivots, CDC Publishes Prevention Measures for Immunocompromised
January 29th 2023In the latest Morbidity and Mortality Weekly Report, authors offer some strategies to avoid SARS-CoV-2 infection in this patient population as well as the US government changes course on COVID-19 vaccine policy.
Read More
Large New Zealand Study Confirms Safety Profile of Pfizer-BioNTech Vaccine
January 26th 2023The Pfizer-BioNTech COVID-19 vaccine was associated with rare instances of myo/pericarditis and acute kidney injury, according to a nationwide study in New Zealand that confirmed the safety profile of the vaccine.
Read More
PREP Act Set to Sunset in 2024 Affecting Half of US States
January 18th 2023This act designed to allow pharmacists and technicians the ability to administer certain vaccines without a prescriber order will lapse next year. A new report looks at vaccination trends in the US and how pharmacists are playing a vital role in administering vaccines.
Read More
Bivalent COVID-19 Booster Vaccination for Children Still Recommended After Safety Review
January 16th 2023A CDC report looked at 2 vaccine safety surveillance systems for the bivalent boosters in this population and there were no reports of myocarditis or death. Many of the reports were due to vaccine errors and not adverse events.
Read More